| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.007 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |